Lori Johnston serves as the Deputy Director at Grifols, where she leverages her extensive expertise in brand strategy and marketing to drive impactful initiatives within the biopharmaceutical sector, particularly focusing on rare diseases and immunology. In her current role, Lori has been instrumental in reshaping...
Lori Johnston serves as the Deputy Director at Grifols, where she leverages her extensive expertise in brand strategy and marketing to drive impactful initiatives within the biopharmaceutical sector, particularly focusing on rare diseases and immunology. In her current role, Lori has been instrumental in reshaping the company's approach to healthcare professional (HCP) engagement. By integrating traditional methods such as speaker programs and advisory boards with cutting-edge digital technologies, she has successfully developed a comprehensive HCP support strategy that enhances peer-to-peer interactions and maximizes outreach effectiveness.
Lori's ability to combine big-picture thinking with meticulous execution has led to the successful launch of several high-impact marketing campaigns that resonate with both HCPs and patients. Her strategic vision not only positions Grifols as a leader in its category but also ensures that the marketing materials developed are aligned with the needs of the target audience, ultimately driving better patient outcomes. Her leadership style fosters a culture of trust and accountability within her teams, inspiring them to thrive in a competitive landscape.
In addition to her strategic prowess, Lori's skills in sales effectiveness and operations have been pivotal in optimizing the performance of field forces across various therapeutic areas, including gastroenterology. By focusing on the development of promotional materials that are both informative and engaging, she ensures that sales teams are equipped to effectively communicate the value of Grifols' innovative products. As a passionate and articulate marketing professional, Lori Johnston continues to make significant contributions to the biopharmaceutical industry, championing initiatives that prioritize patient-centric outcomes while driving organizational success.